PMN
PMN
NASDAQ · Biotechnology

Promis Neurosciences Inc

$10.69
+0.11 (+1.04%)
As of May 16, 2:24 AM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +115.2% upside
Low Target $15.62
Average Target $23.00
High Target $28.09
Current Price $10.69
Current
$10.69
Target
$23.00
$15.62 $23.00 avg $28.09
Scenario Analysis
Bear Case
$15.62
46.1%
Low target
Base Case
$23.00
+115.2%
Avg target
Bull Case
$28.09
+162.8%
High target
Risk/Reward
3.5x
Highly favorable
Price in Context
52-Week High
$39.75
-73.1% from high
52-Week Low
$6.27
+70.5% from low
Target vs 52W High
$23.00
-42.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 75% $257.58 +22.4%
AMGN
Amgen Inc
Hold 44 48% $190.87 -41.5%
GILD
Gilead Sciences Inc
Strong Buy 39 79% $362.68 +179.9%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 +0.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 38 79% $76.80 -89.0%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -64.3%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -21.7%
BIIB
Biogen Inc
Buy 43 56% $91.45 -52.6%